Not approved in the EU: Another setback for the drug tanezumab
The painkiller tanezumab was not approved by the European Medicine's Agency. At the beginning of 2021, news came that tanezumab, a new pain medication, would be launched in the US and Europe. However, in March, tanezumab suffered a setback in the United States when the US Food and Drug Administration rejected the drug for osteoarthritis pain. There was continued uncertainty about the launch of th
https://www.arthritisportal.lu.se/article/not-approved-eu-another-setback-drug-tanezumab - 2025-12-17
